Berlin Chemie

You can help expand this article with text translated from the corresponding article in German. (September 2019) Click [show] for important translation instructions. View a machine-translated version of the German article. Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 2,022 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing German Wikipedia article at [[:de:Berlin-Chemie]]; see its history for attribution. You may also add the template {{Translated|de|Berlin-Chemie}} to the talk page. For more guidance, see Wikipedia:Translation.

Berlin-Chemie Menarini

Company type	Private
Industry	Pharmaceutical industry
Founded	1890
Headquarters	Berlin, Germany Florence, Italy
Key people	Luca Lastrucci (Chairman of the Executive Board) Edward Szybowski Christian Matschke Attilio Sebastio Christiane von der Eltz Ivan Bergstein
Revenue	1.5 billion EUR (2021)[1]
Owner	Menarini Group
Number of employees	5,000 (2021)[1]
Website	www.berlin-chemie.com

Berlin-Chemie Menarini is a German-Italian pharmaceutical company based in Berlin, Germany, and Florence, Italy. The company was formed in 1992 by the merger of the German company Berlin-Chemie and Italian company Menarini.

Berlin-Chemie considers the establishment of a plant for the laboratory preparations of the Chemical factory of Kahlbaum in Berlin-Adlershof in 1890, as its origin.^[2] The first factory located in the former administrative district of Treptow, Berlin-Adlershof.^[3] In 1927 after the merger with Schering AG employees began the development of drugs. After the end of the Second World War, the Adlershof factory of Schering AG was located in the Soviet occupation zone and thus in the later German Democratic Republic. From the mid-50s onwards, the company signed as VEB Berlin-Chemie. When the state-owned companies were privatized or dissolved after the political turnaround, the Italian group Menarini took over the factory in Berlin in 1992, including the product name, and thus immediately found a larger sales market in Eastern Europe.^[4]

In February 2013, Berlin-Chemie took over the Priligy brand, a drug against premature ejaculation. Since mid-2013, there has been a media campaign on the internet and through posters on the subject of premature ejaculation, which many physicians are critical of. According to the imprint of the website in question, Later Come.de, this is a media contribution by Berlin-Chemie AG.^[5]

Since 2015, Berlin-Chemie has been able to manufacture and sell anti-cancer drugs through a license agreement with the Japanese drug manufacturer Chugai.^[6]

The production of infusion solutions was discontinued in 2019.

In 2023, the World Intellectual Property Organization (WIPO)’s Madrid Yearly Review ranked Berlin Chemie's number of marks applications filled under the Madrid System as 6st in the world, with 107 trademarks applications submitted during 2023.^[7]

• Official website

This corporation or company article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e